Dyne Therapeutics, Inc. (DYN)
Market Open
26 Oct, 07:30 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
15. 65
+0.03
+0.1921%
$
2.66B Market Cap
- P/E Ratio
- Div Yield
1.04M Volume
-3.29 Eps
$ 15.62
Previous Close 
Want to track DYN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dyne Therapeutics, Inc. (DYN) Statistics
Valuation metrics
Market Cap 2.66B
Enterprise value 2.26B
Trailing P/E (ttm) -4.69
Forward P/E -
PEG ratio -0.33
Price/Sales (ttm) -
Price/Book (mrq) 3.68
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.42M
Average volume (90 days) 2.79M
Price summary
52-Week low 14
52-Week high 27.31
Beta -
50-Day moving average 16.76
200-Day moving average 20.24
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.52%
Return on equity -0.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 12.02%
Book value per share (mrq) 4.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
